Navigating the Challenges of Technology Transfer in Cell and Gene Therapy: An Interview with Roberto Formisano

Current developments in technology transfer to a Contract Development and Manufacturing Organization (CDMO)

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, discusses the challenges of technology transfer during a video interview. He provides insights on the intricacies of technology transfer, both from development to GMP manufacturing and from a customer to a contract development and manufacturing organization (CDMO).

One of the key challenges Roberto highlights is the critical timelines that are integral to the process of technology transfer. Balancing the number of batches that need to be manufactured to ensure sufficient quality data while adhering to these timelines poses a significant challenge in the industry.

Roberto also shares his predictions on technology and manufacturing trends that are expected to shape the cell and gene therapy industry by 2024. His insights provide valuable perspectives on the future direction of the industry.

Roberto Formisano had a conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March. The interview sheds light on the complexities of technology transfer and offers valuable insights into the industry’s challenges and opportunities.

Leave a Reply